Association of coronary heart disease mortality with risk factors according to length of follow-up and serum cholesterol level in men: The Oslo Study cohort

European Journal of Preventive Cardiology

Volumn 20, Issue 1, 2013, Pages 168-175

  Holme, Ingar ^a   Tonstad, Serena ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Coronary heart disease; metabolic syndrome; mortality; risk factors; triglycerides

Indexed keywords

CHOLESTEROL; GLUCOSE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOMETABOLIC RISK; CARDIOVASCULAR MORTALITY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL; COHORT STUDIES; CORONARY DISEASE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NORWAY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; SMOKING; TIME FACTORS; TRIGLYCERIDES;

EID: 84873925388     PISSN: 20474873     EISSN: None     Source Type: Journal    
DOI: 10.1177/1741826711432514     Document Type: Article

References (33)

1. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the Pooling Project. J Chronic Dis. 1978 ; 31 (4). 201-306
2. Pekkanen J, Nissinen A, Puska P, Punsar S, Karvonen MJ. Risk factors and 25 year risk of coronary heart disease in a male population with a high incidence of the disease: the Finnish cohorts of the seven countries study. BMJ. 1989 ; 299 (1). 81-85
3. Menotti A, Lanti M, Puddu PE. Long-term time-related predictivity of coronary events as a function of a single measurement of serum cholesterol and systolic blood pressure. Acta Cardiol. 2000 ; 55 (1). 87-93
4. Menotti A, Lanti M, Kromhour D, Kafatos A, Nedeljkovic S, Nissinen A. Short and long term association of a single serum cholesterol measurement in middle-aged men in prediction of fatal coronary and other cardiovascular events: a cross-cultural comparison through Europe. Eur J Epidemiol. 2005 ; 20 (7). 597-604
5. Ragland DR, Brand RJ. Coronary heart disease mortality in the Western Collaborative Group Study. Follow-up experience of 22 years. Am J Epidemiol. 1988 ; 127 (3). 462-475
6. Benfante RJ, Reed DM, MacLean CJ, Yano K. Risk factors in middle age that predict early and late onset of coronary heart disease. J Clin Epidemiol. 1989 ; 42 (1). 95-104
7. Welin L, Eriksson H, Larsson B, Svardsudd K, Wilhelmsen L, Tibblin G. Risk factors for coronary heart disease during 25 years of follow-up. The study of men born in 1913. Cardiology. 1993 ; 82 (4). 223-228
8. Pekkanen J, Tervahauta M, Nissinen A, Karvonen MJ. Does the predictive value of baseline coronary risk factors change over a 30-year follow-up?. Cardiology. 1993 ; 82 (2-3). 181-190
9. Wannamethee SG, Shaper AG, Whincup PH, Walker M. Role of risk factors for major coronary heart disease events with increasing length of follow up. Heart. 1999 ; 81 (4). 374-379
10. Menotti A, Kromhout D, Blackburn H, Jacobs D, Lanti M. Early and late coronary deaths in the US Railroad study predicted by major coronary risk factors. Eur J Cardiovasc Prevention Rehab. 2004 ; 11 (4). 382-388
11. Menotti A, Lanti M. Coronary risk factors predicting early and late coronary deaths. Heart. 2003 ; 89 (1). 19-24
12. Wilhelmsen L, Lappas G, Rosengren A. Risk of coronary events by baseline factors during 28 years follow-up and three periods in a random population sample of men. J Intern Med. 2004 ; 256 (3). 298-307
13. Möller CS, Zethelius B, Sundström J, Lind L. Impact of follow-up time and re-measurement of the electrocardiogram and conventional cardiovascular risk factors on their predictive values for myocardial infarction. J Intern Med. 2006 ; 260 (1). 22-30
14. Berry JD, Dyer A, Carnethon M, Tian L, Greenland P, Lloyd-Jones DM. Association of traditional risk factors with cardiovascular death across 0 to 10, 10 to 20, and >20 years follow-up in men and women. Am J Cardiol. 2008 ; 191 (1). 89-94
15. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007 ; 49 (4). 403-414
16. Wilson PWF, Kannel WB, Silbershatz H, D'Agostino RB. Clustering of metabolic factors and coronary heart disease. Arch Intern Med. 1999 ; 159 (2). 114-119
17. Pyörälä M, Miettinen H, Halonen P, Laaskso M, Pyörälä K. Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men. Arterioscler Thromb Vasc Biol. 2000 ; 20 (2). 538-544
18. Delahoy PJ, Magliano DJ, Webb K, Grobler M, Liew D. The relationship between reduction in low-density lipoprotein cholesterol by statins and reduction in risk of cardiovascular outcomes: an updated meta-analysis. Clin Ther. 2009 ; 31 (2). 236-244
19. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009 ; 338 (b165:1-19). 1665-1665
20. Rosenborg L, Kaufman DW, Helmrich SP, Shapiro S. The risk of myocardial infarction after quitting smoking in men under 55 years of age. N Engl J Med. 1985 ; 313 (24). 1511-1514
21. Abourbih S, Filion KB, Joseph L, Schiffrin EL, Rinfret S, Poirier P, et al. Effect of fibrates on lipid profiles and cardiovascular outcomes: a systematic review. Am J Med. 2009 ; 122 (10). 962.e1-8-962.e1-8
22. Montori VM, Fernández-Balsells M. Glycemic control in type 2 diabetes: time for an evidence-based about-face?. Ann Intern Med. 2009 ; 150 (12). 803-808
23. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001 ; 285 (19). 2486-2497
24. Leren P, Askevold EM, Foss OP, Froili A, Grymyr D, Helgeland S, et al. The Oslo Study. Cardiovascular disease in middle-aged and young Oslo men. Acta Med Scand 1975; Suppl 588.
25. Holme I, Helgeland A, Hjermann I, Leren P, Lund-Larsen PG. Four and two-thirds years incidence of coronary heart disease in middle-aged men. The Oslo Study. Am J Epidemiol. 1980 ; 112 (2). 149-160
26. Håheim LL, Tonstad S, Hjermann I, Leren P, Holme I. Predictiveness of body mass index for fatal coronary heart disease in men according to length of follow-up: a 21-year prospective cohort study. Scand J Public Health. 2007 ; 35 (1). 4-10
27. Barr EL, Boyko EJ, Zimmet PZ, Wolfe R, Tonkin AM, Shaw JE. Continuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and lifestyle (AusDiab) study. Diabetologia. 2009 ; 52 (3). 415-424
28. Morrison A, Hokanson JE. The independent relationship between triglycerides and coronary heart disease. Vasc Health Risk Manag. 2009 ; 5 (1). 89-95
29. Nordestgaard BG, Benn M, Schnohr P, Tybjærg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA. 2007 ; 298 (3). 299-308
30. Stensvold I, Tverdal A, Urdal P, Graff-Iversen S. Non-fasting serum triglyceride concentration and mortality from coronary heart disease and any cause in middle aged Norwegian women. BMJ. 1993 ; 307 (6915). 1318-1322
31. Teo KK, Ounpuu S, Hawken S, Pardey MR, Valentin V, Hunt D, et al. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case control study. Lancet. 2006 ; 368 (9536). 647-658
32. Prospective Studies Collaboration, Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths. Lancet 2007; 370(9602): 1829-39.
33. Faergeman O, Holme I, Fayyad R, Bhatia S, Grundy SM, Kastelein JJP, et al. Plasma triglycerides and cardiovascular events in the treating to new targets and incremental decrease in end-points through aggressive lipid lowering trials of statins in patients with coronary artery disease. Am J Cardiol. 2009 ; 104 (4). 459-463